Voronoi, Inc. (KOSDAQ:310210)
South Korea · Delayed Price · Currency is KRW 287,000
+5,000 (1.77%)
Apr 10, 2026, 3:30 PM KST
Voronoi Revenue
In the year 2025, Voronoi had annual revenue of 7.51B KRW. Voronoi had revenue of 22.06M in the quarter ending December 31, 2025.
Revenue
7.51B
Revenue Growth
n/a
P/S Ratio
687.29
Revenue / Employee
53.66M
Employees
140
Market Cap
5.16T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.51B | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.77B | -5.02B | -33.93% |
| Dec 31, 2021 | 14.78B | 8.60B | 139.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Epis Holdings | 3.02T |
| SK Biopharmaceuticals | 706.74B |
| SK bioscience | 651.37B |
| PharmaResearch | 536.29B |
| Hugel | 425.11B |
| LigaChem Biosciences | 141.55B |
| HLB Co., Ltd. | 84.17B |
| OliX Pharmaceuticals | 14.67B |